Phathom Pharmaceuticals, Inc. Common Stock - Çeyreklik Mali Tablolar (NASDAQ:PHAT) | MetaTrader

Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Market Capitalization 1.01 B
Employee 371
Founded 2018
CEO N/A
Website www.phathompharma.com
Headquarter Delaware, United States
FIGI BBG00P5B2S19
Industry Biyoteknoloji

Toplam gelir

Net kar

Temel hisse başına kazanç (Temel EPS)

Total debt

Free cash flow

Nakit ve eşdeğerleri

1.01 B Piyasa değeri

Fiyat/kazanç oranı

-5.48

Price to sales ratio

6.91

Haberler

Rocket Pharmaceuticals ve Argan seans öncesi yükseldi

Barclays, Phathom Pharmaceuticals hissesini yükseltti

Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study

ImmunityBio Rises on China Nod to Bladder Cancer Combo Therapy

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

Mirum Completes Enrollment in Late-Stage EXPAND Study of Livmarli

COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM

Phathom Pharmaceuticals, Inc. (PHAT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Guggenheim, Phathom hissesi için hedef fiyatı 25 dolara yükseltti

Phathom Pharmaceuticals, Inc. (PHAT) Q4 2025 Earnings Call Transcript

Stifel, Phathom hissesi için Al tavsiyesini yineledi